To boost the nation’s access to much-needed diagnostics, the agency allowed certain certified laboratories and manufacturers to proceed with their own clinical tests for COVID-19—provided they validate the tests themselves and submit their data and official applications to the FDA within 15 days for review.
03.20.20Topcon Announces Customer Initiatives to Combat Global COVID-19 Crisis
03.26.20Live Webcast: COVID-19 Impact on Retina Practices
Source: Eyewire News
03.20.20Keeping Your Vision Safe During a Natural Disaster